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New Technology Reveals Physiology*Robert A. Levine, MD,y Ehud Schwammenthal, MD, PHD,z Jae-Kwan Song, MDxSEE PAGE 1984T he most effective therapy demands the mostcomplete understanding of the mechanism.Noninvasive imaging has provided key early
observations of left ventricular outﬂow tract (LVOT)
narrowing and ﬂow acceleration in hypertrophic
cardiomyopathy (HCM) (1,2), resulting from develop-
mental abnormalities (3). On the basis of these ob-
servations, the original lift (Venturi) theory for
LVOT obstruction by systolic anterior motion (SAM)
of the mitral valve in HCM implicated upper septal
hypertrophy as the sole culprit, but was therefore
unable to explain residual SAM after upper
septal reduction or SAM without septal hypertrophy
(4–12). Those observations were subsequently ex-
plained by a more complete understanding of the
interaction of mitral valve structural abnormalities
with altered ﬂow, which positions slack leaﬂet por-
tions into the path of ﬂow diverted by a bulging
septum to affect the posterior leaﬂet surface
and generate form-drag forces pushing the leaﬂet
anteriorly; these are compounded by Venturi lift
forces later in systole as the LVOT narrows and
ﬂow accelerates above the valve (13–23). An impor-
tant element in understanding the role of mitral
valve abnormalities in causing SAM was the*Editorials published in the Journal of the American College of Cardiology
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leaﬂet (13) is pre-positioned in the outﬂow tract,
such that even low ﬂow rates can move the distal
leaﬂet anteriorly and superiorly to occlude the
outﬂow tract.
Why does this pre-positioning occur (Figure 1)?
Certainly, anterior papillary muscle (PM) positioning
anteriorly and leaﬂet elongation may predispose to
it; but, because motion of structures is driven by
ﬂow-induced forces, this leaﬂet orientation suggests
the inﬂuence of as yet unknown ﬂow vectors ori-
ented to push the leaﬂet anteriorly. Because Doppler
color ﬂow mapping can only provide velocity com-
ponents parallel to the beam, until now, actual
ﬂow vectors relative to cardiac structures, which
could provide greater pathophysiologic information,
could be estimated but not precisely determined
(26–28).As in the case of noninvasive measurement
of pressure gradients from Doppler velocities,
Doppler technology has yielded its richest clinical
rewards when combined with ﬂuid mechanics, the
conservation principles of classical mechanics
applied to ﬂuids within ingeniously-selected control
volumes. In this issue of the Journal, Ro et al. (29)
have now applied a novel technology that provides
vector maps of intracardiac ﬂows from Doppler
velocity components. The vectors are derived using
the stream function of ﬂow by applying conservation
laws to measured Doppler velocity components
within volumes of interest containing noncompress-
ible blood.
The investigators applied this technology to
answer our original question of leaﬂet pre-positioning
FIGURE 1 Comparison of Positioning and Movement of the Distal Mitral Leaﬂet From End Diastole to Early Systole in Normal Control and HCM Patients
(Top) Normal control patients and (middle and bottom) hypertrophic cardiomyopathy (HCM) patients. Anterior motion of the posterior leaﬂet as the leaﬂets move
toward closure (late diastole and during isovolumic contraction) before onset of systolic anterior motion (arrows) is prominent in HCM, normally absent.
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1997in HCM: the majority of patients with obstruction
have swirling ﬂow vortices (26) that affect the pos-
terior leaﬂet surfaces from below, moving them
anteriorly. These vortices are generated by late-
diastolic mitral inﬂow within the conﬁned upper
ventricular cavity, and pre-position the distal leaﬂets
into the oncoming systolic wave, creating what can
be termed diastolic anterior motion (DAM) as a pre-
cursor to SAM. In the remainder of patients, septal
geometry redirects even the earliest, low-velocity
systolic ﬂows beneath the posterior leaﬂet, produc-
ing drag or pushing forces that drive SAM.
The study conﬁrms that SAM results from
anatomically-predisposed leaﬂets that protrude into
these late diastolic/early systolic ﬂows. Once SAM
has begun, additional vectors directed posteriorly
into the cul-de-sac beneath the posterior leaﬂet pro-
vide insight into its progression, and might conceiv-
ably help explain its resolution through a competing
“negative or reverse Venturi” (14). Venturi forces act
perpendicular to the axis of high-velocity jets. Such
forces may act not only on the outﬂow side of the
leaﬂets in an anterior direction (reinforcing SAM-
septal contact), but also on their posterior surfacein an opposing direction, initiating detachment of
the leaﬂet from the septum, and thus promoting
resolution of SAM.
Clinical implications of these ﬁndings include
a better understanding of how abnormal valvu-
lar structures interact with ﬂows determined by
abnormal ventricular geometry, for example, to cause
residual SAM with potential for dynamic obstruction
in patients following septal reduction. These ﬁndings
highlight the importance of septal reduction over a
sufﬁcient axial length to minimize anteriorly-directed
vortex ﬂows and ﬂow redirected to affect the poste-
rior leaﬂet surface to reduce residual SAM. These
results further support the potential of leaﬂet modi-
ﬁcation and papillary muscle reorientation to reduce
the anatomic substrate for SAM (30–39).
It will, therefore, be of great interest to learn how
these ﬂows change in patients with septal reduction,
and how those changes correlate with residual SAM,
obstruction, and mitral regurgitation (20). An
intriguing future direction would combine 3-dimen-
sional assessment of cardiac structure with compu-
tational ﬂow modeling to answer the even more basic
question of how these structures create abnormal
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1998vortices in the ﬁrst place, and how we might ulti-
mately “sculpt” LV geometry to ensure the most
physiologic outﬂow without obstruction (26).
Thus, this study uses a new technology to answer a
longstanding question, indicating how SAM has a
late-diastolic impetus, generated by diastolic anterior
motion—DAM leading to SAM—which may be modi-
ﬁed therapeutically. On a more general note, these
observations emphasize that, due to the cyclic natureof cardiac action, phenomena occurring during one
cardiac phase can best be understood by also
considering the impact of the preceding one.
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